ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility to Advance Cell and Gene Therapy

URLhttps://www.pharmasalmanac.com/articles/probio-ope
SourcePharma's Almanac
Date Published06/30/2025

Additional Reshoring Information:

Company/Division name ProBio
Parent companyProBio
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):110
Year reshoring announced:2025
Year reshoring implemented or to be implemented:2025
City reshored to:Hopewell
State(s) reshored to:NJ
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredpharma
What domestic positive factors made reshoring more attractive?Eco-system synergies, Impact on domestic economy, Infrastructure, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market
Find Reshoring Articles